crisaborole
Selected indexed studies
- Crisaborole. (, 2006) [PMID:32401464]
- Crisaborole for atopic dermatitis. (Aust Prescr, 2019) [PMID:31937994]
- Off-Label Therapeutic Potential of Crisaborole. (J Cutan Med Surg, 2020) [PMID:32133868]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Crisaborole. (2006) pubmed
- Crisaborole for atopic dermatitis. (2019) pubmed
- Off-Label Therapeutic Potential of Crisaborole. (2020) pubmed
- Crisaborole: A Novel Nonsteroidal Topical Treatment for Atopic Dermatitis. (2019) pubmed
- Crisaborole 2% Ointment (Eucrisa) for Atopic Dermatitis. (2019) pubmed
- Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. (2016) pubmed
- Crisaborole, Dupilumab, and Sarilumab. (2017) pubmed
- Efficacy and safety of Ruxolitinib, Crisaborole, and Tapinarof for mild-to-moderate atopic dermatitis: a Bayesian network analysis of RCTs. (2024) pubmed
- Atopic Dermatitis: Diagnosis and Treatment. (2020) pubmed
- Crisaborole: Phosphodiesterase inhibitor for treatment of atopic dermatitis. (2017) pubmed